Login
$PRTA
$8.52 +$0.12 (1.43%) Live

Company Executives

$PRTA Management Team

Dr. Lars Ekman

Chairman Emeritus

Age 75
Compensation $304.9K USD
Sex Male

Dr. Gene Kinney

President

Chief Executive Officer

Director

Age 56
Compensation $7.231M USD
Sex Male

Mr. Tran Nguyen

Chief Financial Officer

Chief Strategy Officer

Age 51
Compensation $2.594M USD
Sex Male

Mr. Brandon Smith

Chief Operating Officer

Age 50
Compensation $2.504M USD
Sex Male

Ms. Karin Walker

Chief Accounting Officer

Age 61
Compensation -
Sex Female

Dr. Wagner Zago

Chief Scientific Officer

Age 52
Compensation $2.412M USD
Sex Male

Mr. Michael Malecek

Chief Legal Officer

Company Secretary

Age 59
Compensation $1.178M USD
Sex Male

Mr. Daniel Welch

Independent Chairman of the Board

Age 67
Compensation $2.668M USD
Sex Male

Dr. Chad Swanson

Chief Development Officer

Age 53
Compensation -
Sex Male
Directors
8
serving now
Independent
0 of 1
stated in the proxy; 7 not stated
Average tenure
10.0 years
from year joined
CEO also chairs the board
No
Daniel G. Welch
Director Age On board Independent Committees Other public boards 2025 pay Source
Richard T. Collier
72 2012
14 years
Not stated
Audit Committee
None stated $175,831
Shane M. Cooke
63 2012
14 years
Not stated None stated Alkermes plc $183,331
William H. Dunn, Jr.
56 2023
3 years
Not stated None stated None stated $170,557
Lars G. Ekman
76 2012
14 years
Not stated
Audit Committee
None stated $175,831
Gene G. Kinney
57 2016
10 years
Not independent None stated None stated Paid as CEO
Dennis J. Selkoe
82 2013
13 years
Not stated
Compensation Committee
None stated $172,331
Daniel G. Welch
68 2024
2 years
Not stated
Compensation Committee
Structure Therapeutics Inc., Ultragenyx Pharmaceuticals Inc. Not stated
Helen S. Kim
Not stated Not stated Not stated None stated None stated $160,831

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Mar 27, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support